Wei Liu

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

Ying Jiang, Aihua Sun, Yang Zhao et al. · Nature · 2019 · 980 citations

Life Sciences, Molecular Biology, Oncology +14

Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization

Wei Liu, Yuluo Rong, Jiaxing Wang et al. · Journal of Neuroinflammation · 2020 · 608 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations

Ted W. Johnson, Paul Richardson, Simon Bailey et al. · Journal of Medicinal Chemistry · 2014 · 585 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Parthenolide promotes the repair of spinal cord injury by modulating M1/M2 polarization via the NF-κB and STAT 1/3 signaling pathway

Gaojian Tao, Linwei Li, Zheng Zhou et al. · Cell Death Discovery · 2020 · 179 citations · Full text

Medicine, Neurology, Neuroscience +17

ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis

Anbin Wang, Haisu Dai, Yi Gong et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 149 citations · Full text

Medicine, Cancer Biology, Oncology +17